Quick Answer: An EU Product Information File (PIF) is the product-specific compliance file that the Responsible Person keeps for a cosmetic placed on the EU market. Under Article 11 of Regulation (EC) No 1223/2009, it includes an identifiable product description, the Cosmetic Product Safety Report, manufacturing method and GMP statement, relevant claims evidence, and animal-testing data. It must remain readily accessible at the Responsible Person’s labelled address and be retained for ten years after the last batch is placed on the market.
Last reviewed: 25 September 2026. Editorial review: MOOYAM cosmetic compliance content team. This is practical B2B information, not product-specific legal advice.
What is the purpose of a cosmetic PIF?
The Product Information File is the evidence trail a competent authority can inspect to identify a cosmetic product and assess its compliance. Article 11 of Regulation (EC) No 1223/2009 assigns the file to the EU Responsible Person (RP). It is not an EU-issued certificate or a public marketing brochure. It should accurately reflect the product actually placed on the market, including its final formula, packaging, manufacturing route and claims.
The PIF is related to, but different from, the Cosmetic Product Safety Report (CPSR). The CPSR is a crucial safety component of the PIF; it is not the whole file. Similarly, a CPNP notification is a separate electronic notification step under Article 13, not a replacement for keeping the PIF. The European Commission’s cosmetics legislation overview identifies the main regulatory framework and related guidelines.
What must a PIF contain?
Article 11(2) lists five categories of information, updated as necessary. The legal categories matter more than a supplier’s preferred binder template. Supporting records can be arranged in electronic or other format, provided the RP can make the file readily accessible to the relevant competent authority and the information can be understood by that authority.
| Article 11 PIF component | What it means in practice | Typical handoff question |
|---|---|---|
| Product description | Clear identification so the file can be attributed to the exact cosmetic product. | Do name, SKU, formula version, shade and packaging records point to the same product? |
| Cosmetic Product Safety Report | The Article 10 and Annex I safety report, including Part A information and Part B qualified assessment. | Does the signed assessment cover the final formulation and intended use? |
| Manufacturing method and GMP statement | Description of the manufacturing method plus a statement on compliance with good manufacturing practice under Article 8. | Can the manufacturer supply current, product-relevant process and quality information? |
| Proof of claimed effect, where justified | Evidence for the claimed effect when the nature or effect of the product justifies it. | Does the final label or sales copy make claims that require substantiation? |
| Animal-testing data | Data on animal testing performed by the manufacturer, agents or suppliers relating to product or ingredient development or safety, including testing for third-country requirements. | Have suppliers and partners answered the relevant disclosure request accurately? |
The animal-testing entry should not be replaced with an unsupported “cruelty-free” statement. Article 11 specifies a data category; a certification or marketing claim is a different matter. A brand should ask suppliers for an accurate response and let the RP assess how the legal requirement applies.
Where must the file be kept, and for how long?
Article 11(3) requires the RP to make the PIF readily accessible in electronic or other format at the RP’s address indicated on the label to the competent authority of the Member State where the file is kept. The information must be available in a language easily understood by that authority. The file must be retained for ten years following the date on which the last batch of the cosmetic was placed on the market. The retention clock is tied to the last batch, not simply the initial launch date.
“Readily accessible” means more than knowing that a factory somewhere has a folder. The RP needs an agreed access route, current index and reliable version control. Electronic storage can be practical, but ensure that contracts, staff changes, supplier changes and account access do not strand the records. The RP address on the product label should align with the operator responsible for the file; see the separate guide to EU Responsible Person requirements for non-EU brands.
Who provides the PIF material?
The RP has the statutory file duty, but it normally receives inputs from several parties. A non-EU brand should establish the handoff before bulk production, especially where the manufacturer controls confidential formulation or supplier details. The qualified safety assessor needs sufficient access to complete Part B of the CPSR; the RP needs to retrieve the resulting report and the remaining PIF components. Contracts can protect trade secrets without erasing the need for an accessible compliance record.
| Party | Typical PIF contribution | What to verify |
|---|---|---|
| EU Responsible Person | Maintains the identifiable, up-to-date file and makes it accessible to authorities at the labelled address. | Document index, secure access, update owner and ten-year retention plan. |
| Qualified safety assessor | Completes the CPSR using relevant product evidence and records warnings or restrictions. | Signed final assessment matches the marketed product. |
| Cosmetic OEM/ODM manufacturer | Provides formula and manufacturing information, GMP statement support, specifications, stability or microbiology records as applicable. | Records are traceable to commercial batches and current materials. |
| Brand owner/importer | Controls final product identity, claims, artwork and route to market; coordinates supplier disclosures. | Claims evidence and variants match the final sales presentation. |
As a manufacturing partner, MOOYAM can help organise technical inputs, but it does not automatically become the EU RP. For document preparation, see the practical CPSR evidence checklist. The RP and qualified assessor make the final regulatory and safety judgements.
How does the PIF relate to CPNP notification?
CPNP is the European Commission’s portal for the product information submitted under Article 13 before market placement. The Commission’s CPNP guidance page describes the portal and its users. Notification is not approval, and a portal entry does not host or substitute for the complete PIF. A brand’s launch checklist therefore needs both a finished file and an accurate notification, along with applicable labelling and other obligations.
How should a brand maintain a PIF after launch?
- Keep one master index. Identify the final product, all controlled versions and the owner of each record.
- Connect the CPSR to live specifications. Formula, packaging and use instructions should match the assessment.
- Track artwork and claims. Review new product-page or label claims against the evidence and assessment.
- Capture manufacturing and supplier changes. A new ingredient grade, fragrance, preservative system or pack may require review.
- Escalate safety information. Undesirable effects and new toxicological evidence should reach the RP and assessor promptly.
- Test retrieval. Periodically confirm that the RP can actually produce the current PIF and cited supporting records.
Commission Implementing Decision 2013/674/EU calls the CPSR the key safety element of the PIF and describes collaboration between the RP and assessor. Keeping the file current is more important than producing a polished binder once and then ignoring material changes. If an original SKU is discontinued, retain the file for the legal period after the last batch was placed on the market.
Common PIF mistakes
- Calling an INCI list, ISO certificate or CPNP acknowledgement the complete PIF.
- Keeping a CPSR for a pilot formula while selling a revised commercial formula.
- Storing all evidence with a non-EU manufacturer but giving the RP no reliable access.
- Missing proof for claims that require substantiation.
- Assuming the ten-year retention period begins at launch rather than after the last batch placed on the market.
Frequently asked questions
Is a PIF required for every cosmetic placed on the EU market?
Article 11 requires the RP to keep a PIF when a cosmetic is placed on the market. The file must clearly identify the product to which it relates.
Is the PIF the same as the CPSR?
No. The CPSR is one required part of the wider PIF, which also contains product identification, manufacturing/GMP information, applicable claims evidence and animal-testing data.
Can the PIF be electronic?
Yes. Article 11 allows electronic or other format, provided it is readily accessible at the labelled RP address to the competent authority.
How long must the RP keep the PIF?
Ten years after the last batch of the cosmetic product was placed on the market.
Does CPNP notification mean the PIF has been approved?
No. CPNP is a notification system. It does not replace the RP’s obligation to maintain the PIF or the product’s other legal requirements.
Official sources
- Regulation (EC) No 1223/2009, Articles 10–13 — EUR-Lex.
- Commission Implementing Decision 2013/674/EU, CPSR guidelines — EUR-Lex.
- Cosmetic Product Notification Portal — European Commission.
Planning an EU-ready product file? MOOYAM provides cosmetic OEM/ODM manufacturing and technical documentation support for international beauty brands. Discuss formula, packaging and quality-record needs through our OEM/ODM service; your appointed EU RP should control the final PIF.
Regulatory requirements may change. Brands should verify current requirements with the relevant regulatory authority or a qualified compliance professional before placing cosmetic products on the market.